CFO transition
NusaTrip Incorporated CFO transition: Loïc Gautier to succeed Wallace Tzi Chun Foo
NusaTrip Incorporated reported in a Form 8-K filed June 9, 2026 that Loïc Gautier will succeed Wallace Tzi Chun Foo as Chief Financial Officer, effective June 2, 2026.
In the filing's words
On June 2, 2026 the Board appointed Loïc Gautier (“Mr. Gautier”) as Chief Financial Officer of the Company, effective June 2, 2026.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | NusaTrip Incorporated (NUTR) |
|---|---|
| Event | Transition |
| Incoming | Loïc Gautier |
| Outgoing | Wallace Tzi Chun Foo |
| Title in the filing | Chief Financial Officer |
| Effective | June 2, 2026 |
| 8-K filed | June 9, 2026 |
| Internal promotion | Yes |
| Prior role (per filing) | Designated Board Representative, NusaTrip Incorporated |
| SEC CIK | 0002006468 |
NusaTrip Incorporated reported this change in a Form 8-K, Item 5.02, filed June 9, 2026. The filing's own words are quoted above.
Also filed in June 2026
Other CFO moves on the record that month. All moves.
4 months ago· 2026-06-30TransitionBANX
ArrowMark Financial Corp. CFO transition: Katherine Jones to succeed Patrick Farrell
4 months ago· 2026-06-30InterimIMNN
Imunon, Inc. names Josh Blacher interim CFO
4 months ago· 2026-06-30TransitionRANI
Rani Therapeutics Holdings, Inc. CFO transition: Nicholas M. Maestas to succeed Svai Sanford
4 months ago· 2026-06-29InterimCVKD
Cadrenal Therapeutics, Inc. names John P. Sharp interim CFO
4 months ago· 2026-06-29TransitionGCO
Genesco Inc. CFO transition: Jonathan Collins to succeed Mimi E. Vaughn
4 months ago· 2026-06-29TransitionTNYA
Tenaya Therapeutics, Inc. CFO transition: Eric Hyllengren, M.B.A. to succeed Faraz Ali, M.B.A.
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about Loïc Gautier? Send a correction with the primary source.